期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 611, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2021.121240
关键词
Sirolimus; Supercritical anti-solvent fluidized bed; Excipient; Drug release; Bioavailability
In this study, the impact of excipients on the pharmaceutical properties of sirolimus in the SAS-FB process was evaluated. Co-precipitation of excipients and sirolimus was found to affect the specific surface area of the carrier and drug yield. Among the tested excipients, the formulation containing polyvinylpyrrolidone K30 showed the highest drug yield and significantly improved oral bioavailability compared to the Rapamune tablet. Characterization of the processed API was conducted to understand the mechanism by which excipients contributed to drug dissolution properties.
Enhanced drug release and bioavailability of poorly soluble active pharmaceutical ingredient (API) can be achieved via a fluidized bed coating integrated with supercritical anti-solvent (SAS-FB) - a process of precipitating drug particles onto carrier granules. However, in the absence of excipients, SAS-FB often results in crystalline of the API on the surface of carriers, limiting the improvement of pharmaceutical properties. Coprocessing with excipients is considered an effective approach to improve drug release in the SAS-FB process. Our study used sirolimus, an immune suppressive agent, as the model API to characterize excipients for their effect on pharmaceutical properties in the SAS-FB process. We show that co-precipitation of excipients and sirolumus impacts on carrier specific surface area and drug yield. Among the tested excipients, formulation containing polyvinylpyrrolidone K30 achieved the highest drug yield. Importantly, compared with Rapamune (R) tablet, our optimized formulation displayed a superior in vivo oral bioavailability by 3.05-fold in Sprague-Dawley rats and 3.99-fold in beagle dogs. A series of characterization of the processed API was performed to understand the mechanism by which excipients contributed to drug dissolution properties. Our study provides a useful guidance for the use of excipients in the SAS-FB technology to improve pharmaceutical properties of sirolimus and other poorly soluble drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据